Insider Purchases: Inside the Buy

Tag: Biotech Investing

Cartoon illustration of Illumina headquarters glowing under a DNA-shaped light beam, with a stock chart climbing in the background and two executives holding shopping bags labeled

May 15, 2025

🔬 Illumina (ILMN): Let’s Illuminate the Bull Case!

After losing nearly 80% of its value since 2021, Illumina (ILMN) may be ready for a glow-up. CEO Jacob Thaysen and CFO Ankur Dhingra just bought big, and institutional holders are still hanging on. What do they see—and should you see it too?

Read entire article

Tags: Biotech Humor, Biotech Investing, CEO Buys, CEO insider buying, CEOBuyIn, CEOConfidence, CFO Bought Shares, CFO Insider Buying, Contrarian, contrarian investing, Contrarian Play, Contrarian Stocks, ContrarianPlays, DNA Stocks, Funanc1al, Funanc1al for Investors, Funanc1al Investing, Funanc1alInvesting, Future Health Tech, Genomics, Growth Stocks, Illumina, ILMN, ILMN Stock, Innovation Investing, Insider Buys, Science Stocks, Sequencing Stocks, Share buybacks, Turnaround Stocks

Your cart

Insider Purchases: Inside the Buy

Tag: Biotech Investing

May 15, 2025

🔬 Illumina (ILMN): Let’s Illuminate the Bull Case!

Quick links

Contact us

About us

Follow us